Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19The New England journal of medicine, 2021-04, Vol.384 (16), p.1491-1502 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2100433Full text available |
|
2 |
Material Type: Article
|
Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectivesThe European respiratory journal, 2019-01, Vol.53 (1), p.1801887 [Peer Reviewed Journal]Copyright ©ERS 2019. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright ©ERS 2019 2019 ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.01887-2018 ;PMID: 30545970Full text available |
|
3 |
Material Type: Article
|
Real estimates of mortality following COVID-19 infectionThe Lancet Infectious Diseases, 2020-07, Vol.20 (7), p.773-773 [Peer Reviewed Journal]2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;Distributed under a Creative Commons Attribution 4.0 International License ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30195-X ;PMID: 32171390Digital Resources/Online E-Resources |
|
4 |
Material Type: Article
|
CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection FractionCanadian journal of cardiology, 2021-04, Vol.37 (4), p.531-546 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0828-282X ;EISSN: 1916-7075 ;DOI: 10.1016/j.cjca.2021.01.017 ;PMID: 33827756Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromesEuropean heart journal, 2020-01, Vol.41 (3), p.407-477 [Peer Reviewed Journal]The European Society of Cardiology 2019. All rights reserved. For permissions please email: journals.permissions@oup.com. 2019 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehz425 ;PMID: 31504439Full text available |
|
6 |
Material Type: Article
|
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19International Journal of Antimicrobial Agents, 2020-04 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.ijantimicag.2020.105932Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
Correlation Between 3790 Quantitative Polymerase Chain Reaction–Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 IsolatesClinical infectious diseases, 2021-06, Vol.72 (11), p.e921-e921 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciaa1491Full text available |
|
8 |
Material Type: Article
|
The 'Digital Twin' to enable the vision of precision cardiologyEuropean heart journal, 2020-12, Vol.41 (48), p.4556-4564 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Distributed under a Creative Commons Attribution 4.0 International License ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;ISSN: 0195-668X ;ISSN: 1522-9645 ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa159 ;PMID: 32128588Full text available |
|
9 |
Material Type: Article
|
Evaluation of the effects of sodium–glucose co‐transporter 2 inhibition with empagliflozin on morbidity and mortality in patients with chronic heart failure and a preserved ejection fraction: rationale for and design of the EMPEROR‐Preserved TrialEuropean journal of heart failure, 2019-10, Vol.21 (10), p.1279-1287 [Peer Reviewed Journal]Attribution - NonCommercial ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1596 ;PMID: 31523904Digital Resources/Online E-Resources |
|
10 |
Material Type: Article
|
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trialEuropean heart journal, 2021-03, Vol.42 (13), p.1203-1212 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa1007 ;PMID: 33420498Full text available |
|
11 |
Material Type: Article
|
Antibiotic Adjuvants: Make Antibiotics Great AgainJournal of medicinal chemistry, 2019-10, Vol.62 (19), p.8665-8681 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0022-2623 ;EISSN: 1520-4804 ;DOI: 10.1021/acs.jmedchem.8b01781Digital Resources/Online E-Resources |
|
12 |
Material Type: Article
|
Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicineEuropean heart journal, 2021-01, Vol.42 (2), p.152-161 [Peer Reviewed Journal]The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. 2020 ;The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehaa736 ;PMID: 33099609Full text available |
|
13 |
Material Type: Article
|
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?International journal of antimicrobial agents, 2020-05 [Peer Reviewed Journal]Attribution - NonCommercial - NoDerivatives ;ISSN: 0924-8579 ;EISSN: 1872-7913 ;DOI: 10.1016/j.ijantimicag.2020.105938Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart FailureJournal of the American College of Cardiology, 2021-03, Vol.77 (11), p.1397-1407 [Peer Reviewed Journal]2021 The Authors ;Attribution - NonCommercial - NoDerivatives ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2021.01.044 ;PMID: 33736821Full text available |
|
15 |
Material Type: Article
|
Chloroquine for the 2019 novel coronavirus SARS-CoV-2International Journal of Antimicrobial Agents, 2020-03 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;DOI: 10.1016/j.ijantimicag.2020.105923Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020-07 [Peer Reviewed Journal]2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Attribution - NonCommercial ;ISSN: 0924-8579 ;EISSN: 1872-7913 ;DOI: 10.1016/j.ijantimicag.2020.105949Digital Resources/Online E-Resources |
|
17 |
Material Type: Article
|
Targeting transforming growth factor-β receptors in pulmonary hypertensionThe European respiratory journal, 2021-02, Vol.57 (2), p.2002341 [Peer Reviewed Journal]Copyright ©ERS 2021. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0903-1936 ;EISSN: 1399-3003 ;DOI: 10.1183/13993003.02341-2020 ;PMID: 32817256Full text available |
|
18 |
Material Type: Article
|
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fractionEuropean heart journal, 2022-02, Vol.43 (5), p.416-426 [Peer Reviewed Journal]The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. 2021 ;The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. ;Attribution - NonCommercial ;ISSN: 0195-668X ;EISSN: 1522-9645 ;DOI: 10.1093/eurheartj/ehab798 ;PMID: 34878502Full text available |
|
19 |
Material Type: Article
|
Empagliflozin in Heart Failure with a Preserved Ejection FractionThe New England journal of medicine, 2021-10, Vol.385 (16), p.1451-1461 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107038 ;PMID: 34449189Full text available |
|
20 |
Material Type: Article
|
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology SocietyEuropean journal of heart failure, 2020-11, Vol.22 (11), p.1945-1960 [Peer Reviewed Journal]Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 1388-9842 ;EISSN: 1879-0844 ;DOI: 10.1002/ejhf.1920 ;PMID: 32463967Digital Resources/Online E-Resources |